Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Angkool Kerdpanich"'
Autor:
Veerachai Watanaveeradej, Timothy P. Endy, Sriluck Simasathien, Angkool Kerdpanich, Napuschon Polprasert, Chanchai Aree, David W. Vaughn, Ananda Nisalak
Publikováno v:
Emerging Infectious Diseases, Vol 12, Iss 11, Pp 1770-1772 (2006)
Antibodies to chikungunya virus were detected by hemagglutination-inhibition assay in 33.6% of 2,000 infants' cord sera at delivery. Follow-up of 24 seropositive infants showed that the half-life of antibody persistence was 35.5 days. Chikungunya vir
Externí odkaz:
https://doaj.org/article/e17d37ebb46743138ccd659eb7cd821c
Autor:
Sumita Roy-Ghanta, Pio Lopez, Ping Li, Gerco Haars, Terry Nolan, Juan Carlos Tinoco, Lily Yin Weckx, Fong Seng Lim, David W. Vaughn, Marco Aurélio Palazzi Sáfadi, Miguel Angel Rodriguez Weber, Rolando Ulloa-Gutierrez, Abiel Mascareñas de los Santos, Serge Durviaux, Angkool Kerdpanich, Marcela Hernandez-de Mezerville, Sylvia Taylor, Idis Faingezicht, Yang Feng, Eduardo Lazcano-Ponce, Charissa Borja-Tabora, Aurelio Cruz-Valdez
Publikováno v:
The Journal of Infection
Summary Background Better population data on respiratory viruses in children in tropical and southern hemisphere countries is needed. Methods The epidemiology of respiratory viruses among healthy children (6 months to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaa924bf1d8bc6ad70f8db0e72046816
https://doi.org/10.1016/j.jinf.2016.09.003
https://doi.org/10.1016/j.jinf.2016.09.003
Autor:
Rafael De La Barrerra, Elodie Tournay, Angkool Kerdpanich, Kenneth H. Eckels, A Nisalak, Veerachai Watanaveeradej, Francis Dessy, Stephen J. Thomas, Robert V. Gibbons, Jean-François Toussaint, Bruce L. Innis, Sriluck Simasathien, Richard G. Jarman
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Safety and immunogenicity of two formulations of a live-attenuated tetravalent dengue virus (TDEN) vaccine produced using rederived master seeds from a precursor vaccine were tested against a placebo control in a phase II, randomized, double blind tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fd4cf87124fab579e018da117f2609c
https://doi.org/10.4269/ajtmh.13-0452
https://doi.org/10.4269/ajtmh.13-0452
Autor:
Thomas Breuer, Pio Lopez, Lily Yin Weckx, Gary Dubin, Idis Faingezicht, Miguel Angel Rodriguez Weber, Rolando Ulloa-Gutierrez, Bruce L. Innis, Eduardo Lazcano-Ponce, Serge Durviaux, Aurelio Cruz-Valdez, David W. Vaughn, Abiel Mascareñas de los Santos, Terry Nolan, Fong Seng Lim, Pensri Kosuwon, May Montellano, Louis Fries, Angkool Kerdpanich, Marco Aurélio Palazzi Sáfadi, Juan Carlos Tinoco, Sandra Litao, Charissa Borja-Tabora, Sumita Roy-Ghanta, Marcela Hernandez-de Mezerville, Ping Li
Publikováno v:
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
The Journal of Infectious Diseases
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
The Journal of Infectious Diseases
GlaxoSmithKline Biologicals Background. the vaccine efficacy (VE) of 1 or 2 doses of AS03-adjuvanted influenza A(H1N1) vaccine relative to that of 2 doses of nonadjuvanted influenza A(H1N1) vaccine in children 6 months to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d631b1be0a1ed5db8e948a4cb23910a
https://doi.org/10.1093/infdis/jiu173
https://doi.org/10.1093/infdis/jiu173
Autor:
Yang Feng, Li-Min Huang, Peter E. Silas, Paul Lei, Angkool Kerdpanich, Paul Qaqundah, Robert Jeanfreau, Mohamed El Idrissi, Miguel Angel Rodriguez Weber, Jeanne-Marie Devaster, Yu-Lung Lau, Varsha K. Jain, Noris Pavía-Ruz, Bruce L. Innis, E. Anthony S. Nelson, Mathieu Peeters, Mark M. Blatter
Publikováno v:
Human Vaccines & Immunotherapeutics
The trivalent inactivated influenza vaccine Fluarix™ is licensed in the US for adults and children from 3 years old. This randomized observer-blind study (NCT00764790) evaluated Fluarix™ at two doses; 0.25 ml (Flu-25) and 0.5 ml (Flu-50) in child
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b395c06d118721f192d744a87b00537f
https://doi.org/10.4161/hv.25363
https://doi.org/10.4161/hv.25363
Autor:
Chanchai Aree, Timothy P. Endy, Sriluck Simasathien, David W. Vaughn, Rudiwilai Samakoses, Veerachai Watanaveeradej, Angkool Kerdpanich, Cynthia Ho, Napuschon Polprasert, Ananda Nisalak
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 69:123-128
Antibodies of all four dengue virus serotypes were detected by hemagglutination inhibition (HI) in 97% of 2,000 infants' cord sera at the time of delivery. In comparison with 250 mother-infant's paired sera, we found that 53% of the infants' serum HI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::083f907f153f3ef8299db424b0c0291b
https://doi.org/10.4269/ajtmh.2003.69.123
https://doi.org/10.4269/ajtmh.2003.69.123
Autor:
Abiel Mascareñas de los Santos, Lily Yin Weckx, Idis Faingezicht, Marco Aurélio Palazzi Sáfadi, Yang Feng, Marcela Hernandez-de Mezerville, Eduardo Lazcano-Ponce, Gerco Haars, Miguel Angel Rodriguez Weber, Rolando Ulloa-Gutierrez, Terry Nolan, Pio Lopez, Serge Durviaux, Aurelio Cruz-Valdez, Juan Carlos Tinoco, Charissa Borja-Tabora, Lim Fong Seng, Angkool Kerdpanich, Sumita Roy-Ghanta, David W. Vaughn, Ping Li, Sylvia Taylor
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases
Clinical Infectious Diseases
In children aged 6 months to
Background. The high burden of respiratory syncytial virus (RSV)-associated morbidity and mortality makes vaccine development a priority. Methods. As part of an efficacy trial of pandemic influenza vaccines (NCT01051
Background. The high burden of respiratory syncytial virus (RSV)-associated morbidity and mortality makes vaccine development a priority. Methods. As part of an efficacy trial of pandemic influenza vaccines (NCT01051
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40b01caf8c5de7a0d837d124917a2370
https://pubmed.ncbi.nlm.nih.gov/25673560
https://pubmed.ncbi.nlm.nih.gov/25673560
Autor:
Watanaveeradej, Chanchai Aree, Sriluck Simasathien, Angkool Kerdpanich, Napuschon Polprasert, Ananda Nisalak, Timothy P. Endy, David W. Vaughn
Publikováno v:
Emerging Infectious Diseases, Vol 12, Iss 11, Pp 1770-1772 (2006)
Antibodies to chikungunya virus were detected by hemagglutination-inhibition assay in 33.6% of 2,000 infants' cord sera at delivery. Follow-up of 24 seropositive infants showed that the half-life of antibody persistence was 35.5 days. Chikungunya vir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d675e187361bdeff2dddfb24428cc0da
https://doi.org/10.3201/eid1211.051560
https://doi.org/10.3201/eid1211.051560
Autor:
Wolfgang Jilg, Veerachai Watanveerade, Tino F. Schwarz, Ping Li, May Montellano, Gérard Zalcman, Serge Fitoussi, David W. Vaughn, Angkool Kerdpanich, Odile Launay, Xavier Duval, Vinod Bambure, Paul Gillard, Adrian Caplanusi, Anuradha Madan, Jürgen J. Wenzel
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, BioMed Central, 2013, 13 (1), pp.435. ⟨10.1186/1471-2334-13-435⟩
BMC Infectious Diseases, BioMed Central, 2013, 13 (1), pp.435. ⟨10.1186/1471-2334-13-435⟩
Pandemic influenza vaccine manufacturing capacity and distribution agility is enhanced through the availability of equivalent antigen-sparing vaccines. We evaluated equivalence in terms of immunogenicity between GlaxoSmithKline Vaccines’ A/Californ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8267ecf34b2938ffe505d0a3ad5bf45e
https://www.hal.inserm.fr/inserm-00868824
https://www.hal.inserm.fr/inserm-00868824
Autor:
Detchvijitr, Suwanpakdee, Rudiwilai, Samakoses, Sayomporn, Sirinavin, Angkool, Kerdpanich, Sriluck, Simasathien, Sudaluck, Thunyaharn, Surang, Dejsirilert, Veerachai, Watanaveeradej
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 93
To describe the clinical course, serotype distribution and antimicrobial resistance patterns of invasive pneumococcal disease (IPD) cases in a public hospital.Retrospective review of IPD cases occurring from January 2004 through December 2008 was per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2f601baebea517c110ec57debaab968c
https://pubmed.ncbi.nlm.nih.gov/21294380
https://pubmed.ncbi.nlm.nih.gov/21294380